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Poster Session II S345from 38-96 mg/kg/day. Total MPA Css concentrations ranged
between 1.1-3.9 mcg/mL (mean 2.17 6 0.76 mcg/mL). Total
MPA steady-state clearance (CLss) values ranged between 7.8-
28.6 mL/min/kg. Therapeutic total MPA Css levels were main-
tained in these patients for a duration of 10-30 days. Patients tol-
erated the infusion well and no infusion-related reactions or other
adverse events occurred.
In conclusion, we show that continuous infusion of MMF is
safe and feasible, and successfully achieves and maintains tar-
geted steady-state concentrations of MPA. We have extended
our pilot protocol in order to study the clinical impact and
pharmacokinetics of a continuous infusion of MMF for GVHD
prophylaxis on a larger and more diverse pediatric BMT popula-
tion in our institution.534
DYNAMICS OF DONOR T CELL ACTIVATION DURING EARLY PHASE OF
GRAFT VERSUS HOST DISEASE (GVHD): DONOR ANTIGEN PRESENTING
CELLS CAN ACTIVATE ALLOGENEIC T CELLS
Sadeghi, B.1,2, Al-Hashmi, S.1,2, Hassan, Z.1,2,3, Hassan,M.1,2 1Karolin-
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Graft-versus-host disease (GVHD) is a major complication to he-
matopoietic stem cell transplantation (HSCT). The role of host an-
tigen presenting cells in the activation of donor T-cells has been
reported previously. In the present investigation we tracked host
and donor immune cells in a chronological approach to determine
phenotypical and biological activation patterns during early stages
of GVHD.
Female BALB/c mice were conditioned using busulfan and
cyclophosphamide and transplanted using either male C57BL/6
(allogeneic) or BALB/c (syngeneic) donors. Recipient mice were
killed at day 0,+1,+3,+5,+7 and +21 post BMT; spleen and BM
were assessed for phenotype and function of immune cells. Serum
cytokines were measured and histopathology and immunohisto-
chemistry examinations were carried out to confirm emergence
of GVHD.
GVHD occurred 7 days after allogeneic BMT. Donor dendritic
cells (DCs) significantly expanded and matured early after allo-
BMT (day+3) compared to that observed for host DCs expansion.
T-cells repopulation was similar in both allogeneic and syngeneic
group until day+3. However, donor CD8+ cell expansion, five days
after BMT was 230% compared to that observed in control. IL2,
IFN-gamma and TNF-alfa were at the highest level at day +5 which
were compatible with T-cell activation. Upon activation most of
na€ıve T-cells gain effector-memory phenotype and migrated from
the spleen to periphery.
Tracking of host versus donor immune cell at early phase of
GVHD have shown that donor DCs has essential role in the activa-
tion of donor allogeneic T-lymphocyte. Moreover, during activation
phase of T-cells in the spleen donor na€ıve cells gain effector-memory
phenotype and initiate GVHD.Table 1. Resource utilizatiom associated with CGVHD in first 2 yea
Characteristic MRD
N 29
Median outpatient visits (range) 49 (13-236) days
CMV infection 11 (38%)
Fungal infection 5 (17%)
Median IVIG infusions (range) 6 (3-16)
Median RBC transfusion (range) 14 (2-31)
Median platelet transfusion (range) 14 (4-168)
Total hospitalizations* 59
Median hospitalizations/patient (range) 3 (1-8)
Median hospital stay/admit (range) 18 (1-139)
*Hospitalizations occured in 18 (62%) MRD, 15 (68%) UCB and 8 (18%) contr535
IS IT IMPORTANT TO PERFORM LIVER BIOPSY AFTER ALLOGENEIC
TRANSPLANTATION?
Zak, P., Zavrelova, A., Cermanova, M., Jebavy, L., Belohlavkova, P.
Charles University, Faculty of Medicine and University Hospital, Hradec
Kralove, Czech Republic
Purpose: to evaluate how often was liver impairment caused due to
graft versus host disease after allogeneic transplantation.
Methods: From year 2004 to 2007 we performed liver biopsy in 17
patients (pts) because of the liver impairment after allogeneic stem
cell transplantation. The biopsy was performed in each patient every
time, we could not state the diagnosis from blood tests for sure.
We confirmed GVHD etiology just in 11pts (65%). 4 pts was di-
agnosed with toxic liver impairment, probably due to wide range of
medication. 1 patient was diagnosed with sinusoidal obstructive syn-
drome and in 1 case we proved EBV affection in combination with
autoimune hepatitis. There was no liver failure or progression of
liver function test in 6 pts, which we did not treat as GVHD accord-
ing to the biosy finding. As for liver function testing (bil, ALT, AST,
ALP, GMT) we did not find any important diference in this two co-
hort of pts. Pts with GVHD and other had nearly simmilar labora-
tory results in the time of biopsy.
It was interesting, that in histology examination we proved se-
vere liver hemosiderosis in 8pts (47%) and moderate liver hemosi-
derosis in 5pts (29%). In 6 pts we were also able to evaluate iron
storage in liver tissue, it was increased in each case, in some cases
there was very severe iron overload (range 2860- 11310 mikrog/g
with median 5134 mikrog/g). It corelated with serum ferritin level,
wchich was in range from 1930- 23123 mmol/kg with median
6256mmol/kg.
There was no complication after liver biopsy. In most cases we
performed classical transparietal biopsy. When transjugular biopsy
was performed, there was often no bile duct in the specimen of liver,
and as this is really important for right diagnosis, we had to do re-
biopsy in some cases.
Conclusion:we conclude, that after allogeneic transplantation is re-
ally important to do the liver biopsy and not to treat pts with immu-
nosupression without histological confirmation. It is also very
important to evaluate the liver storage of iron, because most patient
is heavy overload.
The study was supported by Research project of the Ministry of
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THE ECONOMIC BURDEN OF CHRONIC GRAFT-VERSUS-HOST DISEASE: A
RESOURCE UTILIZATION STUDY AMONG ADULT RECIPIENTS OF
MATCHED SIBLING DONOR AND UMBILICAL CORD BLOOD HEMATOPOI-
ETIC CELL TRANSPLANTATION
Sandhu, K.S., Arora, M., Alam, N., Burns, L.J., Weisdorf, D.J.,
Majhail, N.S. University of Minnesota, Minneapolis, MN
Chronic graft-versus-host disease (CGVHD) can impair quality
of life and is associated with significant morbidity and mortality
among allogeneic hematopoietic cell transplant (HCT) recipients.rs post-HCT
UCB Controls
22 45
37 (10-121) days 20 (4-90) days
8 (36%) 6 (13%)
3 (14%) 0
5 (3-14) 1 (1-10)
5 (1-30) 1 (1-3)
7 (1-95) 1 (1-19)
56 16
3 (1-12) 1 (1-9)
25 (4-176) 4 (1-69)
ols.
